Skip to content

The effect of dexmedetomidine combined with transcutaneous auricular vagus nerve stimulation on postoperative delirium in elderly patients: A randomized controlled trial

The effect of dexmedetomidine combined with transcutaneous auricular vagus nerve stimulation on postoperative delirium in elderly patients: A randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126330
Enrollment
Unknown
Registered
2026-06-08
Start date
2026-06-15
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Dexmedetomidine combined with taVNS group:Dexmedetomidine anaesthesia was maintained during the operation, taVNS was started 5 minutes after anaesthesia induction and continued for 30 minutes, and taV
Dexmedetomidine group:Intraoperative maintenance of anaesthesia with dexmedetomidine

Sponsors

Jiangnan University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Perform elective non-cardiac surgery under general anesthesia, with operation time >=2 hours and =65 years old. 3. ASA grade I to III. 4. BMI 20.

Exclusion criteria

Exclusion criteria: 1. Patients with severe primary or secondary diseases; 2. Patients with a clear history of neurological or psychiatric disorders or who are using corresponding medications; 3. Patients with drug, alcohol, or other substance addiction; 4. Recent use of cholinergic drugs, anticholinergic drugs, or hormones; 5. Local rashes, infections, skin lesions, ulcers, or scars in the auricular region; 6. Patients allergic to dexmedetomidine; 7. Bradycardia (preoperative heart rate <60 beats per minute); 8. Patients with a history of implanted stimulators (such as pacemakers, implantable vagus nerve stimulators, deep brain stimulators, or spinal cord stimulators), cochlear implants, or metallic implants; 9. Patients who refuse to provide informed consent or refuse the analgesia pump.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative delirium;

Secondary

MeasureTime frame
Heart rate variability analysis;Postoperative pain score;Sleep quality score;Postoperative anxiety score;Postoperative depression score ;Inflammatory cytokines;Intraoperative vasoactive drug dosage;Opioid consumption;Number of patients requiring rescue analgesia;Any postoperative adverse events;

Countries

China

Contacts

Public ContactXian Ding

Jiangnan University Affiliated Hospital

15301516705@163.com+86 153 0151 6705

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026